BTG3 and systemic lupus erythematosus: Over the past decade, studies on various SARDs, particularly systemic lupus erythematosus (SLE), have led to the discovery of autoantibodies targeting nuclear components of patients’ cells, establishing the indirect immunofluorescence assay (IIFA) as the standard method for ANA detection [9,10].